Industry Research Reports

Home > Reports > Service & Software > Lung Cancer Screening Software- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Lung Cancer Screening Software- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Service & Software

Published Date: 2025-02-20

Pages: 100 Pages

Report ld: 4021381

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Lung Cancer Screening Software was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

North American market for Lung Cancer Screening Software was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Lung Cancer Screening Software was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Lung Cancer Screening Software was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global key companies of Lung Cancer Screening Software include Nuance Communications Inc., Eon, Koninklijke Philips N.V., Siemens Healthineers AG, PenRad Technologies Inc., MRS Systems Inc., Magview, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Lung Cancer Screening Software, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Lung Cancer Screening Software by region & country, by Type, and by Application.

The Lung Cancer Screening Software market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lung Cancer Screening Software.

MARKET SEGMENTATION

By Company

Nuance Communications Inc.
Eon
Koninklijke Philips N.V.
Siemens Healthineers AG
PenRad Technologies Inc.
MRS Systems Inc.
Magview

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Cloud-Based
Web-Based

Segment by Application

Control and Monitoring
Data Management
Decision Support

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Lung Cancer Screening Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Lung Cancer Screening Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Lung Cancer Screening Software in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Lung Cancer Screening Software Product Introduction

1.2 Global Lung Cancer Screening Software Market Size Forecast (2020-2031)

1.3 Lung Cancer Screening Software Market Trends & Drivers

1.3.1 Lung Cancer Screening Software Industry Trends

1.3.2 Lung Cancer Screening Software Market Drivers & Opportunity

1.3.3 Lung Cancer Screening Software Market Challenges

1.3.4 Lung Cancer Screening Software Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Lung Cancer Screening Software Players Revenue Ranking (2024)

2.2 Global Lung Cancer Screening Software Revenue by Company (2020-2025)

2.3 Key Companies Lung Cancer Screening Software Manufacturing Base Distribution and Headquarters

2.4 Key Companies Lung Cancer Screening Software Product Offered

2.5 Key Companies Time to Begin Mass Production of Lung Cancer Screening Software

2.6 Lung Cancer Screening Software Market Competitive Analysis

2.6.1 Lung Cancer Screening Software Market Concentration Rate (2020-2025)

2.6.2 Global 5 and 10 Largest Companies by Lung Cancer Screening Software Revenue in 2024

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Screening Software as of 2024)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Cloud-Based

3.1.2 Web-Based

3.2 Global Lung Cancer Screening Software Sales Value by Type

3.2.1 Global Lung Cancer Screening Software Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Lung Cancer Screening Software Sales Value, by Type (2020-2031)

3.2.3 Global Lung Cancer Screening Software Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Control and Monitoring

4.1.2 Data Management

4.1.3 Decision Support

4.2 Global Lung Cancer Screening Software Sales Value by Application

4.2.1 Global Lung Cancer Screening Software Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Lung Cancer Screening Software Sales Value, by Application (2020-2031)

4.2.3 Global Lung Cancer Screening Software Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

5.1 Global Lung Cancer Screening Software Sales Value by Region

5.1.1 Global Lung Cancer Screening Software Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Lung Cancer Screening Software Sales Value by Region (2020-2025)

5.1.3 Global Lung Cancer Screening Software Sales Value by Region (2026-2031)

5.1.4 Global Lung Cancer Screening Software Sales Value by Region (%), (2020-2031)

5.2 North America

5.2.1 North America Lung Cancer Screening Software Sales Value, 2020-2031

5.2.2 North America Lung Cancer Screening Software Sales Value by Country (%), 2024 VS 2031

5.3 Europe

5.3.1 Europe Lung Cancer Screening Software Sales Value, 2020-2031

5.3.2 Europe Lung Cancer Screening Software Sales Value by Country (%), 2024 VS 2031

5.4 Asia Pacific

5.4.1 Asia Pacific Lung Cancer Screening Software Sales Value, 2020-2031

5.4.2 Asia Pacific Lung Cancer Screening Software Sales Value by Region (%), 2024 VS 2031

5.5 South America

5.5.1 South America Lung Cancer Screening Software Sales Value, 2020-2031

5.5.2 South America Lung Cancer Screening Software Sales Value by Country (%), 2024 VS 2031

5.6 Middle East & Africa

5.6.1 Middle East & Africa Lung Cancer Screening Software Sales Value, 2020-2031

5.6.2 Middle East & Africa Lung Cancer Screening Software Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Lung Cancer Screening Software Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Lung Cancer Screening Software Sales Value, 2020-2031

6.3 United States

6.3.1 United States Lung Cancer Screening Software Sales Value, 2020-2031

6.3.2 United States Lung Cancer Screening Software Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Lung Cancer Screening Software Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Lung Cancer Screening Software Sales Value, 2020-2031

6.4.2 Europe Lung Cancer Screening Software Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Lung Cancer Screening Software Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Lung Cancer Screening Software Sales Value, 2020-2031

6.5.2 China Lung Cancer Screening Software Sales Value by Type (%), 2024 VS 2031

6.5.3 China Lung Cancer Screening Software Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Lung Cancer Screening Software Sales Value, 2020-2031

6.6.2 Japan Lung Cancer Screening Software Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Lung Cancer Screening Software Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Lung Cancer Screening Software Sales Value, 2020-2031

6.7.2 South Korea Lung Cancer Screening Software Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Lung Cancer Screening Software Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Lung Cancer Screening Software Sales Value, 2020-2031

6.8.2 Southeast Asia Lung Cancer Screening Software Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Lung Cancer Screening Software Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Lung Cancer Screening Software Sales Value, 2020-2031

6.9.2 India Lung Cancer Screening Software Sales Value by Type (%), 2024 VS 2031

6.9.3 India Lung Cancer Screening Software Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 Nuance Communications Inc.

7.1.1 Nuance Communications Inc. Profile

7.1.2 Nuance Communications Inc. Main Business

7.1.3 Nuance Communications Inc. Lung Cancer Screening Software Products, Services and Solutions

7.1.4 Nuance Communications Inc. Lung Cancer Screening Software Revenue (US$ Million) & (2020-2025)

7.1.5 Nuance Communications Inc. Recent Developments

7.2 Eon

7.2.1 Eon Profile

7.2.2 Eon Main Business

7.2.3 Eon Lung Cancer Screening Software Products, Services and Solutions

7.2.4 Eon Lung Cancer Screening Software Revenue (US$ Million) & (2020-2025)

7.2.5 Eon Recent Developments

7.3 Koninklijke Philips N.V.

7.3.1 Koninklijke Philips N.V. Profile

7.3.2 Koninklijke Philips N.V. Main Business

7.3.3 Koninklijke Philips N.V. Lung Cancer Screening Software Products, Services and Solutions

7.3.4 Koninklijke Philips N.V. Lung Cancer Screening Software Revenue (US$ Million) & (2020-2025)

7.3.5 Koninklijke Philips N.V. Recent Developments

7.4 Siemens Healthineers AG

7.4.1 Siemens Healthineers AG Profile

7.4.2 Siemens Healthineers AG Main Business

7.4.3 Siemens Healthineers AG Lung Cancer Screening Software Products, Services and Solutions

7.4.4 Siemens Healthineers AG Lung Cancer Screening Software Revenue (US$ Million) & (2020-2025)

7.4.5 Siemens Healthineers AG Recent Developments

7.5 PenRad Technologies Inc.

7.5.1 PenRad Technologies Inc. Profile

7.5.2 PenRad Technologies Inc. Main Business

7.5.3 PenRad Technologies Inc. Lung Cancer Screening Software Products, Services and Solutions

7.5.4 PenRad Technologies Inc. Lung Cancer Screening Software Revenue (US$ Million) & (2020-2025)

7.5.5 PenRad Technologies Inc. Recent Developments

7.6 MRS Systems Inc.

7.6.1 MRS Systems Inc. Profile

7.6.2 MRS Systems Inc. Main Business

7.6.3 MRS Systems Inc. Lung Cancer Screening Software Products, Services and Solutions

7.6.4 MRS Systems Inc. Lung Cancer Screening Software Revenue (US$ Million) & (2020-2025)

7.6.5 MRS Systems Inc. Recent Developments

7.7 Magview

7.7.1 Magview Profile

7.7.2 Magview Main Business

7.7.3 Magview Lung Cancer Screening Software Products, Services and Solutions

7.7.4 Magview Lung Cancer Screening Software Revenue (US$ Million) & (2020-2025)

7.7.5 Magview Recent Developments

8 Industry Chain Analysis

8.1 Lung Cancer Screening Software Industrial Chain

8.2 Lung Cancer Screening Software Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Lung Cancer Screening Software Sales Model

8.5.2 Sales Channel

8.5.3 Lung Cancer Screening Software Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Lung Cancer Screening Software Market Trends

Table 2. Lung Cancer Screening Software Market Drivers & Opportunity

Table 3. Lung Cancer Screening Software Market Challenges

Table 4. Lung Cancer Screening Software Market Restraints

Table 5. Global Lung Cancer Screening Software Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Lung Cancer Screening Software Revenue Market Share by Company (2020-2025)

Table 7. Key Companies Lung Cancer Screening Software Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Lung Cancer Screening Software Product Type

Table 9. Key Companies Time to Begin Mass Production of Lung Cancer Screening Software

Table 10. Global Lung Cancer Screening Software Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Screening Software as of 2024)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Lung Cancer Screening Software Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 14. Global Lung Cancer Screening Software Sales Value by Type (2020-2025) & (US$ Million)

Table 15. Global Lung Cancer Screening Software Sales Value by Type (2026-2031) & (US$ Million)

Table 16. Global Lung Cancer Screening Software Sales Market Share in Value by Type (2020-2025)

Table 17. Global Lung Cancer Screening Software Sales Market Share in Value by Type (2026-2031)

Table 18. Global Lung Cancer Screening Software Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 19. Global Lung Cancer Screening Software Sales Value by Application (2020-2025) & (US$ Million)

Table 20. Global Lung Cancer Screening Software Sales Value by Application (2026-2031) & (US$ Million)

Table 21. Global Lung Cancer Screening Software Sales Market Share in Value by Application (2020-2025)

Table 22. Global Lung Cancer Screening Software Sales Market Share in Value by Application (2026-2031)

Table 23. Global Lung Cancer Screening Software Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 24. Global Lung Cancer Screening Software Sales Value by Region (2020-2025) & (US$ Million)

Table 25. Global Lung Cancer Screening Software Sales Value by Region (2026-2031) & (US$ Million)

Table 26. Global Lung Cancer Screening Software Sales Value by Region (2020-2025) & (%)

Table 27. Global Lung Cancer Screening Software Sales Value by Region (2026-2031) & (%)

Table 28. Key Countries/Regions Lung Cancer Screening Software Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 29. Key Countries/Regions Lung Cancer Screening Software Sales Value, (2020-2025) & (US$ Million)

Table 30. Key Countries/Regions Lung Cancer Screening Software Sales Value, (2026-2031) & (US$ Million)

Table 31. Nuance Communications Inc. Basic Information List

Table 32. Nuance Communications Inc. Description and Business Overview

Table 33. Nuance Communications Inc. Lung Cancer Screening Software Products, Services and Solutions

Table 34. Revenue (US$ Million) in Lung Cancer Screening Software Business of Nuance Communications Inc. (2020-2025)

Table 35. Nuance Communications Inc. Recent Developments

Table 36. Eon Basic Information List

Table 37. Eon Description and Business Overview

Table 38. Eon Lung Cancer Screening Software Products, Services and Solutions

Table 39. Revenue (US$ Million) in Lung Cancer Screening Software Business of Eon (2020-2025)

Table 40. Eon Recent Developments

Table 41. Koninklijke Philips N.V. Basic Information List

Table 42. Koninklijke Philips N.V. Description and Business Overview

Table 43. Koninklijke Philips N.V. Lung Cancer Screening Software Products, Services and Solutions

Table 44. Revenue (US$ Million) in Lung Cancer Screening Software Business of Koninklijke Philips N.V. (2020-2025)

Table 45. Koninklijke Philips N.V. Recent Developments

Table 46. Siemens Healthineers AG Basic Information List

Table 47. Siemens Healthineers AG Description and Business Overview

Table 48. Siemens Healthineers AG Lung Cancer Screening Software Products, Services and Solutions

Table 49. Revenue (US$ Million) in Lung Cancer Screening Software Business of Siemens Healthineers AG (2020-2025)

Table 50. Siemens Healthineers AG Recent Developments

Table 51. PenRad Technologies Inc. Basic Information List

Table 52. PenRad Technologies Inc. Description and Business Overview

Table 53. PenRad Technologies Inc. Lung Cancer Screening Software Products, Services and Solutions

Table 54. Revenue (US$ Million) in Lung Cancer Screening Software Business of PenRad Technologies Inc. (2020-2025)

Table 55. PenRad Technologies Inc. Recent Developments

Table 56. MRS Systems Inc. Basic Information List

Table 57. MRS Systems Inc. Description and Business Overview

Table 58. MRS Systems Inc. Lung Cancer Screening Software Products, Services and Solutions

Table 59. Revenue (US$ Million) in Lung Cancer Screening Software Business of MRS Systems Inc. (2020-2025)

Table 60. MRS Systems Inc. Recent Developments

Table 61. Magview Basic Information List

Table 62. Magview Description and Business Overview

Table 63. Magview Lung Cancer Screening Software Products, Services and Solutions

Table 64. Revenue (US$ Million) in Lung Cancer Screening Software Business of Magview (2020-2025)

Table 65. Magview Recent Developments

Table 66. Key Raw Materials Lists

Table 67. Raw Materials Key Suppliers Lists

Table 68. Lung Cancer Screening Software Downstream Customers

Table 69. Lung Cancer Screening Software Distributors List

Table 70. Research Programs/Design for This Report

Table 71. Key Data Information from Secondary Sources

Table 72. Key Data Information from Primary Sources

Table 73. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Lung Cancer Screening Software Product Picture

Figure 2. Global Lung Cancer Screening Software Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Lung Cancer Screening Software Sales Value (2020-2031) & (US$ Million)

Figure 4. Lung Cancer Screening Software Report Years Considered

Figure 5. Global Lung Cancer Screening Software Players Revenue Ranking (2024) & (US$ Million)

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Lung Cancer Screening Software Revenue in 2024

Figure 7. Lung Cancer Screening Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 8. Cloud-Based Picture

Figure 9. Web-Based Picture

Figure 10. Global Lung Cancer Screening Software Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 11. Global Lung Cancer Screening Software Sales Value Market Share by Type, 2024 & 2031

Figure 12. Product Picture of Control and Monitoring

Figure 13. Product Picture of Data Management

Figure 14. Product Picture of Decision Support

Figure 15. Global Lung Cancer Screening Software Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 16. Global Lung Cancer Screening Software Sales Value Market Share by Application, 2024 & 2031

Figure 17. North America Lung Cancer Screening Software Sales Value (2020-2031) & (US$ Million)

Figure 18. North America Lung Cancer Screening Software Sales Value by Country (%), 2024 VS 2031

Figure 19. Europe Lung Cancer Screening Software Sales Value, (2020-2031) & (US$ Million)

Figure 20. Europe Lung Cancer Screening Software Sales Value by Country (%), 2024 VS 2031

Figure 21. Asia Pacific Lung Cancer Screening Software Sales Value, (2020-2031) & (US$ Million)

Figure 22. Asia Pacific Lung Cancer Screening Software Sales Value by Region (%), 2024 VS 2031

Figure 23. South America Lung Cancer Screening Software Sales Value, (2020-2031) & (US$ Million)

Figure 24. South America Lung Cancer Screening Software Sales Value by Country (%), 2024 VS 2031

Figure 25. Middle East & Africa Lung Cancer Screening Software Sales Value, (2020-2031) & (US$ Million)

Figure 26. Middle East & Africa Lung Cancer Screening Software Sales Value by Country (%), 2024 VS 2031

Figure 27. Key Countries/Regions Lung Cancer Screening Software Sales Value (%), (2020-2031)

Figure 28. United States Lung Cancer Screening Software Sales Value, (2020-2031) & (US$ Million)

Figure 29. United States Lung Cancer Screening Software Sales Value by Type (%), 2024 VS 2031

Figure 30. United States Lung Cancer Screening Software Sales Value by Application (%), 2024 VS 2031

Figure 31. Europe Lung Cancer Screening Software Sales Value, (2020-2031) & (US$ Million)

Figure 32. Europe Lung Cancer Screening Software Sales Value by Type (%), 2024 VS 2031

Figure 33. Europe Lung Cancer Screening Software Sales Value by Application (%), 2024 VS 2031

Figure 34. China Lung Cancer Screening Software Sales Value, (2020-2031) & (US$ Million)

Figure 35. China Lung Cancer Screening Software Sales Value by Type (%), 2024 VS 2031

Figure 36. China Lung Cancer Screening Software Sales Value by Application (%), 2024 VS 2031

Figure 37. Japan Lung Cancer Screening Software Sales Value, (2020-2031) & (US$ Million)

Figure 38. Japan Lung Cancer Screening Software Sales Value by Type (%), 2024 VS 2031

Figure 39. Japan Lung Cancer Screening Software Sales Value by Application (%), 2024 VS 2031

Figure 40. South Korea Lung Cancer Screening Software Sales Value, (2020-2031) & (US$ Million)

Figure 41. South Korea Lung Cancer Screening Software Sales Value by Type (%), 2024 VS 2031

Figure 42. South Korea Lung Cancer Screening Software Sales Value by Application (%), 2024 VS 2031

Figure 43. Southeast Asia Lung Cancer Screening Software Sales Value, (2020-2031) & (US$ Million)

Figure 44. Southeast Asia Lung Cancer Screening Software Sales Value by Type (%), 2024 VS 2031

Figure 45. Southeast Asia Lung Cancer Screening Software Sales Value by Application (%), 2024 VS 2031

Figure 46. India Lung Cancer Screening Software Sales Value, (2020-2031) & (US$ Million)

Figure 47. India Lung Cancer Screening Software Sales Value by Type (%), 2024 VS 2031

Figure 48. India Lung Cancer Screening Software Sales Value by Application (%), 2024 VS 2031

Figure 49. Lung Cancer Screening Software Industrial Chain

Figure 50. Lung Cancer Screening Software Manufacturing Cost Structure

Figure 51. Channels of Distribution (Direct Sales, and Distribution)

Figure 52. Bottom-up and Top-down Approaches for This Report

Figure 53. Data Triangulation

Figure 54. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Lung Cancer Screening Software market? zhanKai

The top companies in the global Lung Cancer Screening Software market are Nuance Communications Inc.、Eon、Koninklijke Philips N.V..

Related Reports

Global Lung Cancer Screening Software Market Research Report 2026
The global Lung Cancer Screening Software market was valued at US$ 1706 million in 2025 and is anticipated to reach US$ 5434 million by 2032, at a CAGR of 18.0% from 2026 to 2032.
Published Date: 2026-01-14
Pages: 115
USD 2900.00
(Single User License)
Global Lung Cancer Screening Software Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Lung Cancer Screening Software market is projected to grow from US$ 1706 million in 2025 to US$ 5434 million by 2032, at a CAGR of 18.0% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-01-14
Pages: 132
USD 4900.00
(Single User License)
Lung Cancer Screening Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Lung Cancer Screening Software was estimated to be worth US$ 1706 million in 2025 and is projected to reach US$ 5434 million, growing at a CAGR of 18.0% from 2026 to 2032.
Published Date: 2026-01-14
Pages: 117
USD 3950.00
(Single User License)
Global Lung Cancer Screening Software Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Lung Cancer Screening Software market size was US$ 1706 million in 2025 and is forecast to reach a readjusted size of US$ 5434 million by 2032 with a CAGR of 18.0% during the forecast period 2026-2032.
Published Date: 2026-01-14
Pages: 98
USD 4250.00
(Single User License)
Global Lung Cancer Screening Software Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Lung Cancer Screening Software market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-23
Pages: 126
USD 4900.00
(Single User License)
Global Lung Cancer Screening Software Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Lung Cancer Screening Software market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 77
USD 4250.00
(Single User License)
Global Lung Cancer Screening Software Market Research Report 2025
The global market for Lung Cancer Screening Software was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-20
Pages: 74
USD 2900.00
(Single User License)
Global Lung Cancer Screening Software Market Insights, Forecast to 2030
Market Analysis and Insights: Global Lung Cancer Screening Software Market
Published Date: 2024-04-07
Pages: 89
USD 4900.00
(Single User License)
Lung Cancer Screening Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Lung Cancer Screening Software was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-02-19
Pages: 92
USD 3950.00
(Single User License)
Global Lung Cancer Screening Software Market Research Report 2024
The global Lung Cancer Screening Software market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-11
Pages: 79
USD 2900.00
(Single User License)

Global Lung Cancer Screening Software Market Research Report 2026
The global Lung Cancer Screening Software market was valued at US$ 1706 million in 2025 and is anticipated to reach US$ 5434 million by 2032, at a CAGR of 18.0% from 2026 to 2032.
Published: 2026-01-14
Pages: 115
USD 2900.00 (Single User License)
Global Lung Cancer Screening Software Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Lung Cancer Screening Software market is projected to grow from US$ 1706 million in 2025 to US$ 5434 million by 2032, at a CAGR of 18.0% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-01-14
Pages: 132
USD 4900.00 (Single User License)
Lung Cancer Screening Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Lung Cancer Screening Software was estimated to be worth US$ 1706 million in 2025 and is projected to reach US$ 5434 million, growing at a CAGR of 18.0% from 2026 to 2032.
Published: 2026-01-14
Pages: 117
USD 3950.00 (Single User License)
Global Lung Cancer Screening Software Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Lung Cancer Screening Software market size was US$ 1706 million in 2025 and is forecast to reach a readjusted size of US$ 5434 million by 2032 with a CAGR of 18.0% during the forecast period 2026-2032.
Published: 2026-01-14
Pages: 98
USD 4250.00 (Single User License)
Global Lung Cancer Screening Software Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Lung Cancer Screening Software market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-23
Pages: 126
USD 4900.00 (Single User License)
Global Lung Cancer Screening Software Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Lung Cancer Screening Software market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 77
USD 4250.00 (Single User License)
Global Lung Cancer Screening Software Market Research Report 2025
The global market for Lung Cancer Screening Software was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-20
Pages: 74
USD 2900.00 (Single User License)
Global Lung Cancer Screening Software Market Insights, Forecast to 2030
Market Analysis and Insights: Global Lung Cancer Screening Software Market
Published: 2024-04-07
Pages: 89
USD 4900.00 (Single User License)
Lung Cancer Screening Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Lung Cancer Screening Software was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-02-19
Pages: 92
USD 3950.00 (Single User License)
Global Lung Cancer Screening Software Market Research Report 2024
The global Lung Cancer Screening Software market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-11
Pages: 79
USD 2900.00 (Single User License)